In a syngeneic murine model of mesothelioma anti-CD4+ anti-PD-1/PD-L1 mAb initially induced tumor regression, followed by an accelerated tumor growth concomitant to CD4 T cell recovery37. This evidence concerns the gene CD4 and neoplasm.